Parallax Volatility Advisers’s Acceleron Pharma XLRN Stock Holding History

Parallax Volatility Advisers’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-80,900	Closed	-$13.9M	–	3668
2021 Q3	$13.9M	Buy	+80,900	New	+$10.6M	0.01%	794
2018 Q3	–	Sell	-53,900	Closed	-$2.62M	–	3891
2018 Q2	$2.62M	Buy	+53,900	New	+$1.96M	﹤0.01%	819
2017 Q4	–	Sell	-120,000	Closed	-$4.48M	–	5196
2017 Q3	$4.48M	Hold	120,000	–	–	0.01%	594
2017 Q2	$3.65M	Buy	+120,000	New	+$3.48M	0.01%	663

Parallax Volatility Advisers's XLRN Position: Q4 2021 in Review

Parallax Volatility Advisers sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 102,614 shares — an estimated $17.7M sold.

Parallax Volatility Advisers first reported a position in XLRN in Q2 2017 and held it in 6 quarters. The position peaked at $17.7M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Parallax Volatility Advisers reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Parallax Volatility Advisers sold 102,614 Acceleron Pharma shares in Q4 2021, an estimated $17.7M.
Parallax Volatility Advisers first reported a position in Acceleron Pharma in Q2 2017 and held it in 6 quarters.
Parallax Volatility Advisers's Acceleron Pharma position peaked at $17.7M in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Parallax Volatility Advisers's 13F filing for Q4 2021, filed 14 Feb 2022.